Skip to content

Routine transesophageal echocardiography in severe aortic stenosis

Routine transesophageal echocardiography in severe aortic stenosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00038450
Enrollment
700
Registered
2025-11-24
Start date
2025-11-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I35.0

Interventions

Group 1: The aim of this study is to investigate the clinical impact of routine TEE in addition to TTE for the management of patients with suspected severe aortic stenosis. Routine TEE does not impact

Sponsors

Uniklinik Leipzig
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with suspected or confirmed severe aortic valve stenosis, i.e. patients with severe or moderate-to-severe aortic stenosis on TTE.

Exclusion criteria

Exclusion criteria: • Absence of either TEE or TTE • Insufficient image quality to obtain AVA (aortic valve area) or mean gradient (dP mean) • Patients with suspected severe but confirmed moderate aortic stenosis by in-hospital TTE (without TEE) • Persons <18 years old (aortic stenosis is a disease of elderly patients. Atherosclerotic aortic stenosis does not occur in adolescents)

Design outcomes

Primary

MeasureTime frame
Change in severity of aortic valve stenosis on TEE (compared to the reference method), i.e. from severe to non-severe aortic stenosis or conversely.

Secondary

MeasureTime frame
1. Any findings in TEE that impact the management of severe aortic stenosis, for instance thrombus, vegetations, annulus dimension, bicuspid aortic morphology etc. 2. Any findings in TEE with therapeutic implications, for instance incident left atrial thrombus. 3. Clinical outcome: time-to-aortic valve implantation/replacement, hospitalisations for cardiovascular causes, hospitalisation for heart failure, cardiovascular death, and all-cause death in patients with change in AS severity after TEE compared to patients with consistent results between TEE and TTE, i.e. unchanged severity of AS after TEE. 4. Safety of TEE: any (including suspected) complications that require medical intervention, monitoring, active follow-up or prolongation of hospital stay.

Countries

Germany

Contacts

Public ContactDaniel Lavall

Uniklinik Leipzig

daniel.lavall@medizin.uni-leipzig.de00493419720541

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026